NCT00949611

Wiser Choices in Osteoporosis Choice II: A Decision Aid for Patients and Clinicians

Wiser Choices In Osteoporosis Choice II

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 79 (actual)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: Female
• Age: 50 Years – 90 Years
• Healthy volunteers: Accepted

Summary

Emphasis in treating osteoporosis has been on T-scores rather than overall fracture risk. Fracture Risk Assessment Tool (FRAX) supports a risk sensitive approach to osteoporosis treatment by providing an absolute fracture risk. FRAX combined with a decision aid may promote a shared decision making approach with patients, allowing the clinician and patient to weigh potential fracture risk (without treatment), versus risk reduction with medication (including side effects and costs). OSTEOPOROSIS CHOICE II will test the effectiveness of: * FRAX * FRAX + decision aid * Usual care (no decision aid and no FRAX given to clinician)

Conditions

• Osteoporosis
• Osteopenia
• Fragility Fractures

Interventions

Type	Name	Description
BEHAVIORAL	FRAX + Decision Aid	Clinicians will present patient's with their individualized risk of osteoporotic fracture in 10 years, based on the FRAX risk calculator, as well as sharing a decision aid with them, which shows their risk of fracture, risk reduction on medications, as well as the downsides of the medications.
BEHAVIORAL	FRAX estimated fracture risk	The clinician is provided with the patient's estimated risk of fracture as computed by the FRAX

Timeline

• Start date: 2009-05-01
• Primary completion: 2011-02-01
• Completion: 2011-02-01
• First posted: 2009-07-30
• Last updated: 2016-02-02

Locations

2 sites across 1 country: United States